JOSEPH SCHILL: Open Payments
NPI 1356547327 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 50 payments from 23 companies in 2025. Trend: 2023 $1,536 · 2024 $862 · 2025 $958
Food & beverage: $958
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $174 |
| Xeris Pharmaceuticals, Inc. | 5 | $94 |
| Novo Nordisk Inc | 4 | $77 |
| Corcept Therapeutics | 3 | $74 |
| Madrigal Pharmaceuticals | 3 | $64 |
| Avvisto Therapeutics, LLC | 3 | $48 |
| Sequel Med Tech, LLC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Verity Pharmaceuticals Inc. | 2 | $39 |
| BETA BIONICS, INC. | 2 | $36 |
Products named: GVOKE HYPOPEN, EVENITY, Korlym, REZDIFFRA, REPATHA, CYCLOSET, TWIIST, JARDIANCE.
Industry payments across TX — which companies pay providers there.
